[Beta-lactamine associations. In vitro synergism and clinical results].
D000667:Ampicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000494:pharmacology*; D002512:Cephalothin / Q000627:therapeutic use; D004357:Drug Synergism; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D010068:Oxacillin / Q000627:therapeutic use; D010403:Penicillin Resistance; D010405:Penicillinase; D010406:Penicillins / Q000494:pharmacology*; D011511:Proteus / Q000187:drug effects*; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012706:Serratia marcescens / Q000187:drug effects*
D002511:Cephalosporins; D005839:Gentamicins; D010406:Penicillins; D000667:Ampicillin; D010405:Penicillinase; D002512:Cephalothin; D010068:Oxacillin
Les associations de beta-lactamines. Synergie "in vitro" et résultats cliniques.